Subjective cognitive decline in preclinical Alzheimer's disease
LA Rabin, CM Smart… - Annual review of clinical …, 2017 - annualreviews.org
Older adults with subjective cognitive decline (SCD) in the absence of objective
neuropsychological dysfunction are increasingly viewed as at risk for non-normative …
neuropsychological dysfunction are increasingly viewed as at risk for non-normative …
Subjective cognitive decline in older adults: an overview of self-report measures used across 19 international research studies
Research increasingly suggests that subjective cognitive decline (SCD) in older adults, in
the absence of objective cognitive dysfunction or depression, may be a harbinger of non …
the absence of objective cognitive dysfunction or depression, may be a harbinger of non …
Alzheimer disease
DS Knopman, H Amieva, RC Petersen… - Nature reviews Disease …, 2021 - nature.com
Alzheimer disease (AD) is biologically defined by the presence of β-amyloid-containing
plaques and tau-containing neurofibrillary tangles. AD is a genetic and sporadic …
plaques and tau-containing neurofibrillary tangles. AD is a genetic and sporadic …
Prevalence and risk of progression of preclinical Alzheimer's disease stages: a systematic review and meta-analysis
L Parnetti, E Chipi, N Salvadori, K D'Andrea… - Alzheimer's research & …, 2019 - Springer
Background Alzheimer's disease (AD) pathology begins several years before the clinical
onset. The long preclinical phase is composed of three stages according to the …
onset. The long preclinical phase is composed of three stages according to the …
Neuropsychiatric symptoms associated with cerebral small vessel disease: a systematic review and meta-analysis
U Clancy, D Gilmartin, ACC Jochems, L Knox… - The Lancet …, 2021 - thelancet.com
Background Cerebral small vessel disease, a common cause of vascular dementia, is often
considered clinically silent before dementia or stroke become apparent. However, some …
considered clinically silent before dementia or stroke become apparent. However, some …
From mild cognitive impairment to subjective cognitive decline: conceptual and methodological evolution
Y Cheng, TF Chen, MJ Chiu - Neuropsychiatric Disease and …, 2017 - Taylor & Francis
Identification of subjects at the early stages of Alzheimer's disease (AD) is fundamental for
drug development and possible intervention or prevention of cognitive decline. The concept …
drug development and possible intervention or prevention of cognitive decline. The concept …
APOE effect on Alzheimer's disease biomarkers in older adults with significant memory concern
Introduction This study assessed apolipoprotein E (APOE) ε4 carrier status effects on
Alzheimer's disease imaging and cerebrospinal fluid (CSF) biomarkers in cognitively normal …
Alzheimer's disease imaging and cerebrospinal fluid (CSF) biomarkers in cognitively normal …